Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
7%
Ph not_applicable
12
86%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
1(7.1%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Other(2)

Detailed Status

Completed11
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.1%)
Phase 41 (7.1%)
N/A12 (85.7%)

Trials by Status

completed1179%
not_yet_recruiting17%
unknown214%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14